Showing results (151-160 of 251) with videos related to
Sort By:
Pageof 26
Revista Espanola De Fisiologia|March 1, 1977
[Tubular permeability maintained in post-ischemic acute renal failure (author's transl)]J M López-Novoa, M A Rengel, F J Ortega, et al.American Journal of Hypertension|March 1, 1997
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathyE Villa, A Rábano, M Cazes, et al.American Journal of Hypertension|December 22, 1999
Differential effects of losartan and doxazosin on vascular function in senescent spontaneously hypertensive ratsR Maeso, J Navarro-Cid, E Rodrigo, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 23, 2001
Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuriaE Esmatjes, L Flores, P Iñigo, et al.Journal of Hypertension|March 6, 1999
Effects of antihypertensive therapy on factors mediating endothelium-dependent relaxation in rats treated chronically with L-NAMER Maeso, J Navarro-Cid, E Rodrigo, et al.Journal of Human Hypertension|February 23, 2007
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK studyV Barrios, C Escobar, A Calderón, et al.Transplantation Proceedings|November 14, 2006
Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter studyA Andrés, E Morales, J M Morales, et al.The Journal of Urology|June 1, 1985
Squamous cell carcinoma of the renal pelvis associated with hypercalcemia and the presence of parathyroid hormone-like substances in the tumorR Diaz González, A Barrientos, L Larrodera, et al.Transplantation|October 27, 2004
Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year studyD R J Kuypers, H H Neumayer, L Fritsche, et al.Vaccine|March 1, 1990
Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patientsM Bruguera, J L Rodicio, J M Alcazar, et al.Pageof 26